haloperidol has been researched along with raclopride in 153 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (8.50) | 18.7374 |
1990's | 84 (54.90) | 18.2507 |
2000's | 46 (30.07) | 29.6817 |
2010's | 10 (6.54) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bengtsson, S; de Paulis, T; Hall, H; Högberg, T; Johansson, L; Ogren, SO; Ström, P | 1 |
Bouthenet, ML; Giros, B; Martres, MP; Schwartz, JC; Sokoloff, P | 1 |
Clanton, JA; de Paulis, T; Janowsky, A; Kessler, RM; Smith, HE | 1 |
Angeby-Möller, K; de Paulis, T; Hall, H; Johansson, L; Kumar, Y; Ogren, SO; Rämsby, S; Sällemark, M | 1 |
Foulon, C; Kung, HF; Kung, MP | 1 |
Audinot, V; Chaput, C; Conte, C; Gavaudan, S; Millan, MJ; Newman-Tancredi, A; Touzard, M; Verrièle, L | 1 |
Topliss, JG; Yoshida, F | 1 |
Altomare, C; Asproni, B; Biggio, G; Bitti, M; Busonero, F; Cerri, R; Dazzi, L; Maciocco, E; Melosu, M; Pau, A; Pusceddu, L; Sanna, E; Seu, E; Talani, G; Trapani, G | 1 |
Fang, X; Hu, Z; Levant, B; Min, J; Varady, J; Wang, S; Wu, X | 1 |
Amici, L; Baldessarini, RJ; Baldwin, RM; Fu, X; Innis, RB; Kula, NS; Tamagnan, GD | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Bartenstein, P; Chowdhury, S; Djurova, P; Fricker, G; Höfner, G; Purisima, EO; Schirrmacher, R; Wängler, B; Wängler, C; Wanner, KT | 1 |
Benachour, N; Vanderheyden, PML | 1 |
Fibiger, HC; Robertson, GS | 1 |
Ericson, H; Ross, SB | 1 |
Chapman, MA; Meshul, CK; See, RE | 1 |
Alster, P; Svensson, TH; Uvnäs-Moberg, K | 1 |
Murray, CE; See, RE | 1 |
Day, J; Fibiger, HC | 1 |
Bryske, B; Karlsson-Boethius, G; Köhler, C; Radesäter, AC; Widman, M | 1 |
See, RE | 1 |
Ahlenius, S; Wadenberg, ML | 1 |
Bervoets, K; Mavridis, M; Millan, MJ | 1 |
Coffin, VL; Cohen, M; Iorio, LC | 1 |
Albergati, A; Bo, P; Dallocchio, C; Marchioni, E; Savoldi, F | 1 |
Civelli, O; Creese, I; Riva, M; van Tol, HH | 1 |
Ellison, G; See, RE | 2 |
Ellison, G; See, RE; Toga, AW | 1 |
Allard, P; Eriksson, K; Marcusson, JO; Ross, SB | 1 |
Allikmets, LKh; Kharro, IaE; Lang, AE; Vasar, EE | 1 |
Butcher, LL; Levin, ED; McGurk, SR | 1 |
Fowler, CJ; Vulto, AG | 1 |
Gerlach, J; Kistrup, K | 1 |
Fowler, CJ; Magnusson, O; Mohringe, B; Ogren, SO; Wijkström, A | 1 |
Bo, P; Giorgetti, A; Ongini, E; Savoldi, F | 1 |
Andreasen, NC; Carson, R; Diksic, M; Evans, A; Farde, L; Gjedde, A; Hakim, A; Lal, S; Nair, N; Sedvall, G | 1 |
Fowler, CJ; Thorell, G | 1 |
Ahlenius, S; Fowler, CJ; Hillegaart, V; Magnusson, O | 1 |
Ahlenius, S; Hillegaart, V | 1 |
Ehrin, E; Eriksson, L; Farde, L; Greitz, T; Hall, H; Hedström, CG; Litton, JE; Sedvall, G | 1 |
Deinum, ME; Schuiling, GA; Timmerman, W; Westerink, BH | 1 |
Chio, CL; Drong, RF; Gill, GS; Huff, RM; Riley, DT; Slightom, JL | 1 |
Crabbe, JC; Phillips, TJ; Shen, EH | 1 |
Artigas, F; Ferré, S | 1 |
Bastianetto, S; Perrault, G; Sanger, DJ | 1 |
Asghari, V; Buchwaldt, S; Jovanovic, V; Paterson, A; Sanyal, S; Van Tol, HH | 1 |
Cheetham, SC; Heal, DJ; Martin, KF; Phillips, I | 1 |
Conway, PC; Corbett, R; Dunn, RW; Hartman, H; Helsley, GC; Kerman, LL; Strupczewski, JT; Woods, AT | 1 |
Jackson, DM; Johansson, C; Svensson, L | 1 |
Andersson, I; Gustafsson, K; Westlind-Danielsson, A | 1 |
Glenthøj, B | 1 |
Goldstein, M; Ogren, SO | 1 |
Gerlach, J; Lublin, H; Peacock, L | 1 |
Deutch, AY; Fitzgerald, LW; Gasic, G; Heinemann, SF; Nestler, EJ | 1 |
Ferré, S; Fuxe, K; Li, XM; Ogren, SO; Schwarcz, R; Snaprud, P | 1 |
Atrens, DM; Christie, MJ; Jackson, DM; Lin, HQ; McGregor, IS | 1 |
Goldman-Rakic, PS; Sawaguchi, T | 1 |
Andersson, JL; Marcus, M; Nomikos, GG; Svensson, TH | 1 |
Csernansky, JG; Faustman, WO; Ford, JM; Pfefferbaum, A; Roth, WT; White, PM | 1 |
Fuxe, K; Ogren, SO; Rosén, L | 1 |
Cools, AR; Ellenbroek, BA; Prinssen, EP; Stamatovic, B | 1 |
Shirakawa, O; Tamminga, CA; Tarazi, FI | 1 |
Evans, DL; Figur, LM; Lahti, RA; Stratman, NC | 1 |
Gerlach, J; Peacock, L | 1 |
Carlsson, A; Lagerkvist, S; Löfberg, L; Piercey, M; Waters, N | 1 |
Glenthøj, B; Hemmingsen, R; Holm, S; Laursen, H; Mogensen, J | 1 |
Chase, TN; Kapitzoglou-Logothetis, V; Marin, C; Parashos, SA; Peppe, A | 1 |
Didriksen, M | 1 |
Seeman, P; Van Tol, HH | 1 |
Barnes, TR; Gerlach, J | 1 |
Ishibashi, T; Ishida, K; Nakamura, M; Ohno, Y; Okada, K | 1 |
DaSilva, J; Houle, S; Jones, C; Kapur, S; Remington, G; Wilson, A; Zipursky, R | 1 |
Fukuda, T; Futamura, T; Haga, K; Ohashi, Y; Takahashi, Y; Yano, K | 1 |
Brown, T; Cooper, M; Mukherjee, J; Roemer, J; Yang, ZY | 1 |
Ekman, A; Eriksson, E; Hellstrand, M; Nilsson, CL | 1 |
Harrington, A; Kaczmarek, HJ; Steinpreis, RE | 1 |
Farde, L; Halldin, C; Nyberg, S | 2 |
Kennedy, JL; Nobrega, JN; Sasaki, T | 1 |
Kleven, MS; Koek, W; Prinssen, EP | 2 |
Creese, I; Florijn, WJ; Tarazi, FI | 3 |
Ase, AR; Hébert, C; Huang, N; Reader, TA; van Gelder, NM | 2 |
Lindefors, N; Malmerfelt, A; Marcus, MM; Nomikos, GG; Svensson, TH; Zachrisson, O | 1 |
Bernstein, IL; Roitman, MF; Schafe, GE; Thiele, TE | 1 |
Nakajima, S; Patterson, RL | 1 |
Costall, B; Neill, JC; Smith, JK | 1 |
Cherkerzian, S; Cohen, BM; Ennulat, DJ; Froimowitz, MP; Konieczna, H; Wan, W | 1 |
Mohell, N | 1 |
Hicks, PB; Richter, TJ; Trompler, RA; Wadenberg, ML; Young, KA; Zavodny, RA | 1 |
Liang, X; Wang, RY | 1 |
Ahlenius, S; Malmgren, K; Salmi, P; Svensson, TH | 1 |
Aberman, JE; Salamone, JD; Ward, SJ | 1 |
Fowler, SC; Liou, JR | 1 |
Alvir, JM; Bilder, R; Chakos, M; Creese, I; Kinon, BJ; Lee, H; Lieberman, JA; Redmond, M; Tarazi, FI; Wu, H | 1 |
Dow-Edwards, D; Shi, X; Yin, R | 1 |
Carboni, E; Di Chiara, G; Rolando, MT; Silvagni, A | 1 |
Miñarro, J; Pinazo, J; Rodríguez-Arias, M; Stinus, L | 1 |
Arenas, MC; Monleón, S; Parra, A; Simón, VM; Vinader-Caerols, C | 1 |
Besret, L; Dunnett, SB; Page, KJ | 1 |
Caligiuri, MP; Fitzgerald, PB; Jones, C; Kapur, S; Remington, G; Silvestri, S; Zipursky, RB | 1 |
Booze, RM; Mactutus, CF; Wallace, DR | 1 |
Boulay, D; Depoortere, R; Perrault, G; Sanger, DJ | 1 |
Houle, S; Jones, C; Kapur, S; Remington, G; Zipursky, R | 1 |
McCallum, SE; Porter, JH; Vann, RE; Varvel, SA | 1 |
Kapur, S; Remington, G; Wadenberg, ML | 1 |
Aguilar, MA; Arenas, MC; Miñarro, J; Parra, A; Simón, VM; Vinader-Caerols, C | 1 |
Deutch, AY; Garcia-Espana, A; Goldstein, M; Haycock, JW; Salvatore, MF | 1 |
Hillefors, M; von Euler, G | 1 |
Antoniou, K; Bekris, S; Papadopoulou-Daifoti, Z; Rimikis, M; Saranti, M; Stathis, P | 1 |
Barsoum, SC; Kapur, S; Seeman, P | 1 |
Daskalakis, J; Kapur, S; Remington, G; Roy, P; Zipursky, R | 1 |
De Boer, P; De Vries, JB; Geels, C; Kawahara, Y; Kruse, CG; Long, SK; Van Kalkeren, A; Van Vliet, B; Westerink, BH; Wikström, HV | 1 |
Browning, JL; Hicks, PB; Wadenberg, MG; Young, KA | 1 |
Farde, L; Halldin, C; Nordström, AL; Nyberg, S; Olsson, H; Talvik, M | 1 |
Abercrombie, ED; Zackheim, JA | 1 |
Broft, A; Chatterjee, R; Huang, Y; Hwang, DR; Laruelle, M; Martinez, D; Mawlawi, O; Ngo, K; Simpson, N; Slifstein, M; Van Heertum, R | 1 |
Nadelhaft, I; Vera, PL | 1 |
Adams, JU; Careri, JM; Efferen, TR; Rotrosen, J | 1 |
Bubser, M; Deutch, AY | 1 |
Moran, PM; O'Tuathaigh, CM | 1 |
Kapur, S; Nobrega, JN; Remington, G; Turrone, P | 2 |
Basta-Kaim, A; Budziszewska, B; Jaworska-Feil, L; Kubera, M; Lasoń, W; Leśkiewicz, M; Tetich, M | 1 |
Biala, G; Duarte, C; Hamon, M; Le Bihan, C; Thiébot, MH | 1 |
Ishiwata, K; Kawamura, K; Kobayashi, T; Matsuno, K | 1 |
Lee, J; Rajakumar, N | 1 |
Getova-Spassova, D; Krustev, A; Spassov, V; Turijski, V | 1 |
Burris, KD; Kikuchi, T; Miwa, T; Mori, T; Stark, A; Tadori, Y; Tottori, K | 1 |
Christensen, BK; Daskalakis, Z; Epstein, I; Furimsky, I; Kapur, S; Roy, P; Sanger, T; Zipursky, RB | 1 |
Barth, VN; Chernet, E; Li, D; Martin, LJ; Need, AB; Phebus, LA; Rash, KS | 1 |
Andersson, M; Fuxe, K; Strömberg, I; Terasmaa, A | 1 |
Ceresoli-Borroni, G; Guidetti, P; Rassoulpour, A; Schwarcz, R; Wu, HQ | 1 |
Bastianetto, S; Danik, M; Mennicken, F; Quirion, R; Williams, S | 1 |
Bedi, KS; Bryan-Lluka, LJ; Catts, SV; Catts, VS; Naiker, DV | 1 |
Lee, J; Rajakumar, N; Rushlow, WJ | 1 |
Ball, GF; Castelino, CB; Cornil, CA | 1 |
Brennum, LT; Kreilgaard, M; Olsen, CK | 1 |
Ginovart, N; Houle, S; Hussey, D; Kapur, S; Wilson, AA | 1 |
Fink, G; Pereira, A; Sundram, S | 1 |
Bjelica, A; Rajakumar, N; Rushlow, WJ; Seah, C; Sutton, LP | 1 |
Carayon, P; Couture, R; De Brito Gariepy, H; Ferrari, B | 1 |
D'Aquila, PS | 1 |
Couture, R; De Brito Gariepy, H | 1 |
Aguilar, MA; Daza-Losada, M; Miñarro, J; Rodríguez-Arias, M; Roger-Sánchez, C; Vidal-Infer, A | 1 |
Battaglia, G; Bucci, D; Consolazione, M; Lionetto, L; Maccari, S; Mairesse, J; Marrocco, J; Morley-Fletcher, S; Nicoletti, F; Ravasi, L; Simmaco, M | 1 |
Chen, L; Gao, GD; Ge, SN; Heng, LJ; Jia, D; Li, WX; Yan, ZQ; Yang, C; Zhang, JR; Zhao, TZ; Zhu, JL | 1 |
De Luca, MA; Di Chiara, G; Perra, V; Serra, GP; Tanda, G; Valentini, V | 1 |
4 review(s) available for haloperidol and raclopride
Article | Year |
---|---|
Influence of the cellular environment on ligand binding kinetics at membrane-bound targets.
Topics: Angiotensin II Type 1 Receptor Blockers; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Humans; Kinetics; Ligands; Protein Binding; Receptor, Angiotensin, Type 1; Receptors, Cell Surface; Signal Transduction | 2017 |
Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatum.
Topics: Adult; Corpus Striatum; Haloperidol; Humans; National Institute of Mental Health (U.S.); Raclopride; Receptors, Dopamine; Receptors, Dopamine D2; Salicylamides; Schizophrenia; Schizophrenic Psychology; Spiperone; Tomography, Emission-Computed; United States | 1988 |
Sex differences in the effects of neuroleptics on escape-avoidance behavior in mice: a review.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Escape Reaction; Female; Haloperidol; Male; Mice; Raclopride; Sex Characteristics | 1999 |
Are animal studies of antipsychotics appropriately dosed? Lessons from the bedside to the bench.
Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Male; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Schizophrenia | 2000 |
7 trial(s) available for haloperidol and raclopride
Article | Year |
---|---|
A double-blind comparison of raclopride and haloperidol in the acute phase of schizophrenia. The British Isles Raclopride Study Group.
Topics: Adolescent; Adult; Aged; Dopamine D2 Receptor Antagonists; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Prolactin; Raclopride; Salicylamides; Schizophrenia; Severity of Illness Index | 1992 |
ERPs in schizophrenia: effects of antipsychotic medication.
Topics: Adult; Antipsychotic Agents; Arousal; Cerebral Cortex; Dopamine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Electroencephalography; Evoked Potentials, Auditory; Evoked Potentials, Visual; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Raclopride; Salicylamides; Schizophrenia; Schizophrenic Psychology | 1994 |
High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study.
Topics: Adult; Brain; Carbon Radioisotopes; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Male; Prospective Studies; Psychiatric Status Rating Scales; Raclopride; Receptors, Dopamine D2; Salicylamides; Schizophrenia; Schizophrenic Psychology; Tomography, Emission-Computed | 1996 |
Instrumentally detected changes in motor functioning in patients with low levels of antipsychotic dopamine D2 blockade.
Topics: Adult; Carbon Radioisotopes; Cerebellum; Corpus Striatum; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Female; Haloperidol; Humans; Hypokinesia; Male; Motor Activity; Muscle Rigidity; Raclopride; Receptors, Dopamine D2; Schizophrenia; Schizophrenia, Paranoid; Tomography, Emission-Computed; Tremor | 2000 |
Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia.
Topics: Adolescent; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Carbon Radioisotopes; Corpus Striatum; Dopamine D2 Receptor Antagonists; Double-Blind Method; Female; Haloperidol; Humans; Hyperprolactinemia; Male; Middle Aged; Raclopride; Receptors, Dopamine D2; Schizophrenia; Tomography, Emission-Computed; Treatment Outcome | 2000 |
Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum.
Topics: Adult; Artifacts; Carbon Radioisotopes; Cerebellum; Dopamine; Dopamine Antagonists; Female; Haloperidol; Humans; Male; Middle Aged; Nucleus Accumbens; Raclopride; Receptors, Dopamine D2; Reproducibility of Results; Tomography, Emission-Computed | 2001 |
Treatment response to olanzapine and haloperidol and its association with dopamine D receptor occupancy in first-episode psychosis.
Topics: Acute Disease; Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Corpus Striatum; Dose-Response Relationship, Drug; Double-Blind Method; Female; Haloperidol; Humans; Male; Olanzapine; Positron-Emission Tomography; Psychotic Disorders; Raclopride; Receptors, Dopamine D2; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2005 |
142 other study(ies) available for haloperidol and raclopride
Article | Year |
---|---|
Potential antipsychotic agents 5. Synthesis and antidopaminergic properties of substituted 5,6-dimethoxysalicylamides and related compounds.
Topics: Animals; Antipsychotic Agents; Apomorphine; Binding Sites; Chemical Phenomena; Chemistry; Dopamine Antagonists; Male; Raclopride; Rats; Rats, Inbred Strains; Salicylamides; Spiperone; Structure-Activity Relationship | 1990 |
Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics.
Topics: Amino Acid Sequence; Animals; Antipsychotic Agents; Base Sequence; Brain Chemistry; Cell Line; Cloning, Molecular; Cricetinae; DNA; DNA Restriction Enzymes; Dopamine; Guanylyl Imidodiphosphate; Molecular Sequence Data; Nucleic Acid Hybridization; Polymerase Chain Reaction; Rats; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; RNA, Messenger; Sequence Homology, Nucleic Acid; Tissue Distribution | 1990 |
(S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-[125I]iodo- 2-methoxybenzamide hydrochloride, a new selective radioligand for dopamine D-2 receptors.
Topics: Animals; Benzamides; Chromatography, High Pressure Liquid; Isomerism; Kinetics; Male; Pyrrolidines; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Dopamine | 1988 |
Potential neuroleptic agents. 4. Chemistry, behavioral pharmacology, and inhibition of [3H]spiperone binding of 3,5-disubstituted N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxysalicylamides.
Topics: Animals; Apomorphine; Chemical Phenomena; Chemistry; Corpus Striatum; Haloperidol; Male; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Salicylamides; Spiperone; Stereotyped Behavior; Structure-Activity Relationship | 1986 |
Synthesis of (R,S)-2'-trans-7-hydroxy-2-[N-n-propyl-N-(3'-iodo-2'- propenyl)-amino]tetralin (trans-7-OH-PIPAT): a new D3 dopamine receptor ligand.
Topics: Binding Sites; Dopamine Agents; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Salicylamides; Stereoisomerism; Tetrahydronaphthalenes | 1993 |
Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study.
Topics: Animals; Antipsychotic Agents; CHO Cells; Cricetinae; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Agents; Sulfur Radioisotopes | 1998 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Synthesis and pharmacological evaluation of 1-[(1,2-diphenyl-1H-4-imidazolyl)methyl]-4-phenylpiperazines with clozapine-like mixed activities at dopamine D(2), serotonin, and GABA(A) receptors.
Topics: Animals; Cerebral Cortex; Chloride Channels; Clozapine; Dopamine; Dopamine Antagonists; Drug Design; GABA Antagonists; Humans; Imidazoles; In Vitro Techniques; Oocytes; Piperazines; Quantitative Structure-Activity Relationship; Radioligand Assay; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, GABA-A; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Antagonists; Xenopus laevis | 2002 |
Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: discovery of novel and potent D3 ligands through a hybrid pharmacophore- and structure-based database searching approach.
Topics: Algorithms; Binding Sites; Computational Biology; Crystallography, X-Ray; Databases, Protein; Humans; Kinetics; Ligands; Lipid Bilayers; Models, Molecular; Molecular Conformation; Mutation; Receptors, Dopamine D2; Receptors, Dopamine D3; Reproducibility of Results; Solvents; Structure-Activity Relationship; Tetrahydronaphthalenes; Water | 2003 |
Synthesis and affinity of a possible byproduct of electrophilic radiolabeling of [123I]IBZM.
Topics: Benzamides; Indicators and Reagents; Iodine Radioisotopes; Isotope Labeling; Molecular Structure; Pyrrolidines; Structure-Activity Relationship | 2003 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Shuttle-cargo fusion molecules of transport peptides and the hD2/3 receptor antagonist fallypride: a feasible approach to preserve ligand-receptor binding?
Topics: Amino Acid Sequence; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzamides; Biological Transport; Blood-Brain Barrier; Carrier Proteins; Dopamine Antagonists; Humans; Ligands; Models, Molecular; Molecular Docking Simulation; Molecular Sequence Data; Receptors, Dopamine D2; Receptors, Transferrin; Transcytosis | 2014 |
Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine.
Topics: Animals; Antipsychotic Agents; Benzazepines; Cerebral Cortex; Clozapine; Corpus Striatum; Dopamine Antagonists; Gene Expression Regulation; Genes, fos; Haloperidol; Immunohistochemistry; Male; Molecular Weight; Nucleus Accumbens; Oxidopamine; Prosencephalon; Raclopride; Rats; Rats, Inbred Strains; Salicylamides | 1992 |
Subchronic treatment of rats with remoxipride fails to modify sigma binding sites in the brain.
Topics: Animals; Antipsychotic Agents; Benzamides; Brain; Corpus Striatum; Dopamine Agents; Dopamine Antagonists; Haloperidol; In Vitro Techniques; Liver; Male; Piperidines; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Opioid; Receptors, sigma; Remoxipride; Salicylamides | 1992 |
Comparison of chronic intermittent haloperidol and raclopride effects on striatal dopamine release and synaptic ultrastructure in rats.
Topics: Animals; Antipsychotic Agents; Catalepsy; Caudate Nucleus; Corpus Striatum; Dialysis; Dopamine; Female; Haloperidol; Putamen; Raclopride; Rats; Rats, Sprague-Dawley; Salicylamides; Synapses; Time Factors | 1992 |
Amperozide and clozapine but not haloperidol or raclopride increase the secretion of oxytocin in rats.
Topics: Animals; Antipsychotic Agents; Clozapine; Dopamine Antagonists; Female; Haloperidol; Male; Oxytocin; Piperazines; Raclopride; Rats; Rats, Sprague-Dawley; Salicylamides; Serotonin Antagonists | 1992 |
Changes in striatal dopamine release and metabolism during and after subchronic haloperidol administration in rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dialysis; Dopamine; Dopamine Antagonists; Female; Haloperidol; Homovanillic Acid; Hydroxyindoleacetic Acid; Raclopride; Rats; Rats, Sprague-Dawley; Salicylamides; Time Factors | 1992 |
Dopaminergic regulation of cortical acetylcholine release.
Topics: Acetylcholine; Amphetamine; Animals; Benzazepines; Cerebral Cortex; Dialysis; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; Male; Raclopride; Rats; Rats, Wistar; Salicylamides | 1992 |
Regional distribution and in vivo binding of the atypical antipsychotic drug remoxipride. A biochemical and autoradiographic analysis in the rat brain.
Topics: Animals; Autoradiography; Benzamides; Binding, Competitive; Brain; Brain Chemistry; Chromatography, Liquid; Dopamine Antagonists; Haloperidol; Male; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; Remoxipride; Salicylamides | 1992 |
Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dialysis; Dopamine; Dopamine Antagonists; Drug Tolerance; Female; Haloperidol; Homovanillic Acid; Hydroxyindoleacetic Acid; Raclopride; Rats; Rats, Inbred Strains; Salicylamides | 1991 |
Effects of raclopride and haloperidol on spontaneous motor activity and on conditioned avoidance behavior in rats. A comparison of potency, efficacy and time-course of action.
Topics: Animals; Avoidance Learning; Dose-Response Relationship, Drug; Haloperidol; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Motor Activity; Raclopride; Rats; Rats, Inbred Strains; Salicylamides; Time Factors | 1991 |
The serotonin (5-HT)1A agonist, LY 165,163, induces contralateral rotation in unilateral substantia nigra-lesioned rats via dopamine receptors.
Topics: Alprenolol; Animals; Apomorphine; Benzazepines; Haloperidol; Male; Motor Activity; Oxidopamine; Piperazines; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Salicylamides; Serotonin Antagonists; Substantia Nigra | 1991 |
Anticholinergic drugs potentiate dopamine D1 but not D2 antagonists on a conditioned avoidance task in rats.
Topics: Administration, Oral; Animals; Atropine; Avoidance Learning; Benzazepines; Dopamine Antagonists; Drug Synergism; Escape Reaction; Haloperidol; Male; Parasympatholytics; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Scopolamine | 1991 |
Antagonism of EEGraphic and behavioural effects of methamphetamine by selective receptor blockers (SCH 23390 and raclopride) in the rabbit.
Topics: Animals; Arousal; Behavior, Animal; Benzazepines; Cortical Synchronization; Dopamine Antagonists; Electroencephalography; Haloperidol; Methamphetamine; Motor Cortex; Rabbits; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Stereotyped Behavior | 1991 |
Lack of effect of chronic dopamine receptor blockade on D2 dopamine receptor mRNA level.
Topics: Adrenergic alpha-Antagonists; Animals; Benzazepines; Blotting, Northern; Clozapine; Corpus Striatum; DNA Probes; Dopamine Antagonists; Haloperidol; Male; Quinolines; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D2; RNA, Messenger; Salicylamides | 1990 |
Chronic administration of typical, but not atypical neuroleptics induce persisting alterations in rest-activity cycles in rats.
Topics: Animals; Antipsychotic Agents; Clozapine; Drinking; Female; Fluphenazine; Haloperidol; Motor Activity; Raclopride; Rats; Rats, Inbred Strains; Salicylamides | 1990 |
Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and atypical neuroleptics in rats.
Topics: Animals; Antipsychotic Agents; Brain Chemistry; Clozapine; Dyskinesia, Drug-Induced; Female; Haloperidol; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, GABA-A; Receptors, Muscarinic; Receptors, Neurotransmitter; Salicylamides; Up-Regulation | 1990 |
Unaltered [3H]GBR-12935 binding after chronic treatment with dopamine active drugs.
Topics: Animals; Binding, Competitive; Bromocriptine; Cocaine; Corpus Striatum; Dextroamphetamine; Dopamine Agents; Haloperidol; Kinetics; Male; Piperazines; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Salicylamides | 1990 |
Comparison of chronic administration of haloperidol and the atypical neuroleptics, clozapine and raclopride, in an animal model of tardive dyskinesia.
Topics: Animals; Behavior, Animal; Body Weight; Clozapine; Dibenzazepines; Disease Models, Animal; Drinking; Dyskinesia, Drug-Induced; Female; Fourier Analysis; Haloperidol; Raclopride; Rats; Rats, Inbred Strains; Salicylamides | 1990 |
[Adaptive changes in sigma and phencyclidine receptors during the long-term use of haloperidol and raclopride in rats].
Topics: Adaptation, Physiological; Animals; Apomorphine; Behavior, Animal; Drug Interactions; Haloperidol; Ketamine; Phenazocine; Phencyclidine; Raclopride; Rats; Receptors, Neurotransmitter; Receptors, Opioid; Receptors, Phencyclidine; Receptors, sigma; Salicylamides; Time Factors; Tritium | 1989 |
Radial-arm maze performance in rats is impaired by a combination of nicotinic-cholinergic and D2 dopaminergic antagonist drugs.
Topics: Animals; Benzazepines; Dopamine Antagonists; Drug Interactions; Female; Ganglionic Stimulants; Haloperidol; Mecamylamine; Parasympathomimetics; Psychomotor Performance; Raclopride; Rats; Rats, Inbred Strains; Salicylamides; Scopolamine | 1989 |
The effect of the dopamine agonist pergolide on tyrosine hydroxylase activity in rat striatal and limbic miniprisms in vitro: a model for the dopamine autoreceptor?
Topics: Animals; Corpus Striatum; Dihydroxyphenylalanine; Haloperidol; In Vitro Techniques; Limbic System; Male; Nerve Tissue Proteins; Pergolide; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Salicylamides; Tyrosine 3-Monooxygenase | 1986 |
Selective D1 and D2 receptor manipulation in Cebus monkeys: relevance for dystonia and dyskinesia in humans.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Benzazepines; Biperiden; Cebus; Dystonia; Ergolines; Haloperidol; Male; Movement Disorders; Quinpirole; Raclopride; Receptors, Dopamine; Salicylamides; Stereotyped Behavior | 1987 |
Comparison of the effects of haloperidol, remoxipride and raclopride on "pre"- and postsynaptic dopamine receptors in the rat brain.
Topics: Adrenergic alpha-Agonists; Animals; Antipsychotic Agents; Azepines; Behavior, Animal; Benzamides; Brain; Haloperidol; Levodopa; Male; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Remoxipride; Salicylamides | 1988 |
Synchronization of the EEG and sedation induced by neuroleptics depend upon blockade of both D1 and D2 dopamine receptors.
Topics: Animals; Antipsychotic Agents; Benzazepines; Drug Interactions; Electroencephalography; Haloperidol; Hypnotics and Sedatives; Rabbits; Raclopride; Receptors, Dopamine; Salicylamides | 1988 |
Antagonist effects of the enantiomers of 3-PPP towards alpha 1-adrenoceptors coupled to inositol phospholipid breakdown in the rat cerebral cortex.
Topics: Animals; Antiparkinson Agents; Atropine; Carbachol; Cerebral Cortex; Haloperidol; In Vitro Techniques; Inositol Phosphates; Male; Norepinephrine; Phenoxybenzamine; Piperidines; Prazosin; Raclopride; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Salicylamides; Stereoisomerism; Sugar Phosphates | 1987 |
Increased duration of dopamine receptor antagonist-induced effects on both behaviour and striatal dopamine turnover by repeated testing in rats.
Topics: Animals; Corpus Striatum; Dopamine; Haloperidol; Limbic System; Male; Motor Activity; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Salicylamides | 1988 |
Effects of raclopride on exploratory locomotor activity, treadmill locomotion, conditioned avoidance behaviour and catalepsy in rats: behavioural profile comparisons between raclopride, haloperidol and preclamol.
Topics: Animals; Avoidance Learning; Behavior, Animal; Catalepsy; Exploratory Behavior; Haloperidol; Male; Motor Activity; Piperidines; Raclopride; Rats; Rats, Inbred Strains; Salicylamides; Scopolamine | 1987 |
Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography.
Topics: Animals; Benzamides; Brain; Haloperidol; Humans; Kinetics; Macaca fascicularis; Raclopride; Receptors, Dopamine; Species Specificity; Tissue Distribution; Tomography, Emission-Computed | 1985 |
Lack of evidence for dopamine autoreceptors in the mediobasal hypothalamus: a microdialysis study in awake rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzazepines; Consciousness; Dopamine Antagonists; Haloperidol; Hypothalamus, Middle; Male; Microdialysis; Nomifensine; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine; Salicylamides; Sulpiride | 1995 |
D4 dopamine receptor-mediated signaling events determined in transfected Chinese hamster ovary cells.
Topics: Amiloride; Animals; Arachidonic Acid; Base Sequence; Butaclamol; CHO Cells; Cloning, Molecular; Clozapine; Cricetinae; Cyclic AMP; DNA; Dopamine; Dopamine Antagonists; Ergolines; Genes, Synthetic; Haloperidol; Humans; Kinetics; Molecular Sequence Data; Pertussis Toxin; Protein Kinase C; Quinpirole; Raclopride; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D4; Recombinant Proteins; Salicylamides; Signal Transduction; Sodium-Hydrogen Exchangers; Transfection; Virulence Factors, Bordetella | 1994 |
Dopamine antagonist effects on locomotor activity in naive and ethanol-treated FAST and SLOW selected lines of mice.
Topics: Animals; Benzazepines; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Ethanol; Haloperidol; Mice; Motor Activity; Raclopride; Receptors, Dopamine D1; Salicylamides | 1995 |
Clozapine decreases serotonin extracellular levels in the nucleus accumbens by a dopamine receptor-independent mechanism.
Topics: Animals; Clozapine; Dopamine; Dopamine Agonists; Ergolines; Haloperidol; Microdialysis; Nucleus Accumbens; Quinpirole; Raclopride; Rats; Receptors, Dopamine; Salicylamides; Serotonin; Time Factors | 1995 |
Pharmacological evidence for the involvement of sigma sites in DTG-induced contralateral circling in rats.
Topics: Animals; Anticonvulsants; Behavior, Animal; Carbazoles; Dose-Response Relationship, Drug; Guanidines; Haloperidol; Injections, Spinal; Male; Motor Activity; Phenazocine; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, sigma; Salicylamides | 1995 |
Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants.
Topics: Animals; Benzamides; Cell Line; CHO Cells; Clozapine; Colforsin; Cricetinae; Cyclic AMP; Dinoprostone; Dopamine; Haloperidol; HeLa Cells; Humans; Raclopride; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D4; Recombinant Proteins; Salicylamides; Spiperone; Transfection | 1995 |
Dopamine D2 receptors: a potential pharmacological target for nomifensine and tranylcypromine but not other antidepressant treatments.
Topics: Animals; Antidepressive Agents; Binding, Competitive; Dopamine Antagonists; Electroconvulsive Therapy; Haloperidol; In Vitro Techniques; Male; Membranes; Neostriatum; Nomifensine; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Salicylamides; Tranylcypromine | 1995 |
Effects of atypical antipsychotic agents on social behavior in rodents.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Antipsychotic Agents; Apomorphine; Benzazepines; Catalepsy; Chlorpromazine; Clozapine; Diazepam; Haloperidol; Isoxazoles; Male; Mice; Mice, Inbred Strains; Piperidines; Raclopride; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Serotonin; Risperidone; Salicylamides; Social Behavior | 1993 |
The atypical antipsychotic, remoxipride, blocks phencyclidine-induced disruption of prepulse inhibition in the rat.
Topics: Acoustic Stimulation; Animals; Antipsychotic Agents; Clozapine; Dopamine Agonists; Dose-Response Relationship, Drug; Haloperidol; Male; Phencyclidine; Raclopride; Rats; Rats, Sprague-Dawley; Reflex, Startle; Remoxipride; Salicylamides | 1994 |
Remoxipride shows low propensity to block functional striatal dopamine D2 receptors in vitro.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Animals; Calcium; Colforsin; Corpus Striatum; Cyclic AMP; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; In Vitro Techniques; Male; Pergolide; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Remoxipride; Salicylamides; Structure-Activity Relationship; Sulpiride | 1994 |
Persistent vacuous chewing in rats following neuroleptic treatment: relationship to dopaminergic and cholinergic function.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antipsychotic Agents; Apomorphine; Benzazepines; Benzofurans; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Haloperidol; Male; Parasympathetic Nervous System; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Scopolamine; Stereotyped Behavior | 1993 |
Phencyclidine- and dizocilpine-induced hyperlocomotion are differentially mediated.
Topics: Analysis of Variance; Animals; Dizocilpine Maleate; Dopamine Agonists; Dopamine Antagonists; Ergolines; Haloperidol; Male; Motor Activity; Phencyclidine; Quinpirole; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Remoxipride; Salicylamides | 1994 |
Chronic treatment with the D1 receptor antagonist, SCH 23390, and the D2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment. Extrapyramidal syndromes and dopaminergic supersensitivity.
Topics: Animals; Basal Ganglia Diseases; Behavior, Animal; Benzazepines; Cebus; Dopamine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Female; Grooming; Haloperidol; Hypnotics and Sedatives; Male; Motor Activity; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Stereotyped Behavior; Substance Withdrawal Syndrome | 1993 |
Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs.
Topics: Animals; Antipsychotic Agents; Benzazepines; Cerebral Cortex; Clozapine; Corpus Striatum; Dopamine; Dopamine Antagonists; Gene Expression Regulation; Haloperidol; Humans; Limbic System; Male; Mesencephalon; Mianserin; Models, Neurological; Oxidopamine; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Salicylamides; Schizophrenia; Serotonin; Substantia Nigra | 1995 |
Chronic haloperidol treatment leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum.
Topics: Adenosine; Animals; Antihypertensive Agents; Binding, Competitive; Dopamine D2 Receptor Antagonists; Haloperidol; Kinetics; Male; Membranes; Motor Activity; Neostriatum; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Raclopride; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Purinergic P1; Salicylamides; Theophylline | 1994 |
Contrasting effects of dopaminergic blockade on MDMA and d-amphetamine conditioned taste aversions.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Avoidance Learning; Benzazepines; Dextroamphetamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; Male; N-Methyl-3,4-methylenedioxyamphetamine; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D1; Salicylamides; Taste | 1994 |
The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task.
Topics: Animals; Antipsychotic Agents; Appetitive Behavior; Attention; Benzazepines; Dominance, Cerebral; Dopamine; Dopamine Antagonists; Eye Movements; Fixation, Ocular; Haloperidol; Injections; Ketanserin; Macaca mulatta; Male; Mental Recall; Orientation; Prefrontal Cortex; Raclopride; Reaction Time; Receptors, Dopamine D1; Saccades; Salicylamides; Sulpiride | 1994 |
Prazosin modulates the changes in firing pattern and transmitter release induced by raclopride in the mesolimbic, but not in the nigrostriatal dopaminergic system.
Topics: Animals; Brain; Corpus Striatum; Dopamine D2 Receptor Antagonists; Haloperidol; Injections, Intravenous; Limbic System; Male; Neurotransmitter Agents; Prazosin; Raclopride; Rats; Rats, Sprague-Dawley; Salicylamides; Substantia Nigra | 1994 |
The dopamine D2 antagonist remoxipride acts in vivo on a subpopulation of dopamine D2 receptors.
Topics: Animals; Binding, Competitive; Brain; Catalepsy; Corpus Striatum; Dextroamphetamine; Dose-Response Relationship, Drug; Haloperidol; Limbic System; Male; Motor Activity; Quinolines; Raclopride; Rats; Receptors, Dopamine; Remoxipride; Salicylamides; Substantia Nigra | 1994 |
The effects of haloperidol and raclopride in the paw test are influenced similarly by SCH 39166.
Topics: Animals; Antipsychotic Agents; Basal Ganglia Diseases; Behavior, Animal; Benzazepines; Dopamine D2 Receptor Antagonists; Drug Interactions; Forelimb; Haloperidol; Hindlimb; Male; Raclopride; Rats; Rats, Wistar; Reaction Time; Receptors, Dopamine D1; Salicylamides | 1993 |
Low dose raclopride spares the extrapyramidal system in rat brain from metabolic effects.
Topics: Animals; Antipsychotic Agents; Autoradiography; Brain; Deoxyglucose; Dopamine D2 Receptor Antagonists; Extrapyramidal Tracts; Glucose; Haloperidol; Male; Raclopride; Rats; Rats, Sprague-Dawley; Salicylamides | 1993 |
Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications.
Topics: Animals; Apomorphine; Butyrophenones; Cell Line; Chlorpromazine; Clozapine; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; Raclopride; Radioligand Assay; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D4; Salicylamides; Trifluoperazine | 1993 |
Effects of several partial dopamine D2 receptor agonists in Cebus apella monkeys previously treated with haloperidol.
Topics: Administration, Oral; Amphetamine; Animals; Antipsychotic Agents; Behavior, Animal; Benzothiazoles; Cebus; Disease Models, Animal; Dopamine Agents; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Dystonia; Ergolines; Female; Haloperidol; Lisuride; Male; Piperidines; Pramipexole; Quinpirole; Raclopride; Salicylamides; Thiazoles | 1993 |
The dopamine D3 receptor and autoreceptor preferring antagonists (+)-AJ76 and (+)-UH232; a microdialysis study.
Topics: 3,4-Dihydroxyphenylacetic Acid; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Autoreceptors; Corpus Striatum; Dopamine; Dopamine Antagonists; Haloperidol; Male; Microdialysis; Neurons; Nucleus Accumbens; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Salicylamides; Substantia Nigra; Tetrahydronaphthalenes; Ventral Tegmental Area | 1993 |
Electrical sensitization of the meso-limbic dopaminergic system in rats: a pathogenetic model for schizophrenia.
Topics: Amphetamine; Animals; Apomorphine; Benzazepines; Disease Models, Animal; Dopamine D2 Receptor Antagonists; Electric Stimulation; Electroencephalography; Habituation, Psychophysiologic; Haloperidol; Limbic System; Male; Models, Neurological; Motor Activity; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D1; Salicylamides; Schizophrenia; Seizures; Stereotyped Behavior; Tegmentum Mesencephali; Time Factors | 1993 |
D1 and D2 dopamine receptor-mediated mechanisms and behavioral supersensitivity.
Topics: Animals; Apomorphine; Behavior, Animal; Benzazepines; Catalepsy; Dopamine D2 Receptor Antagonists; Haloperidol; Male; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Salicylamides; Stereotyped Behavior; Up-Regulation | 1993 |
Effects of antipsychotics on cognitive behaviour in rats using the delayed non-match to position paradigm.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Benzazepines; Clozapine; Cognition; Dopamine Antagonists; Haloperidol; Male; Memory; Raclopride; Rats; Rats, Wistar; Salicylamides; Time Factors | 1995 |
Deriving the therapeutic concentrations for clozapine and haloperidol: the apparent dissociation constant of a neuroleptic at the dopamine D2 or D4 receptor varies with the affinity of the competing radioligand.
Topics: Animals; Binding, Competitive; Caudate Nucleus; Clozapine; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Humans; Pituitary Gland; Raclopride; Radioligand Assay; Receptors, Dopamine D2; Salicylamides; Swine | 1995 |
D1 receptor antagonists in schizophrenia.
Topics: Animals; Dopamine Antagonists; Haloperidol; Raclopride; Receptors, Dopamine D1; Salicylamides; Schizophrenia | 1995 |
Effects of subchronic treatments with SM-9018, a novel 5-HT2 and D2 antagonist, on dopamine and 5-HT receptors in rats.
Topics: Animals; Antipsychotic Agents; Binding, Competitive; Haloperidol; Indoles; Isoindoles; Male; Raclopride; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Serotonin; Salicylamides; Serotonin Antagonists; Thiazoles; Up-Regulation | 1995 |
[The affinities of mosapramine for the dopamine receptor subtypes in human cell lines expressing D2, D3 and D4 receptors].
Topics: Antipsychotic Agents; Benzazepines; Cell Line; Clozapine; Haloperidol; Humans; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D4; Receptors, Dopamine D5; Risperidone; Salicylamides; Spiperone | 1996 |
18F-desmethoxyfallypride: a fluorine-18 labeled radiotracer with properties similar to carbon-11 raclopride for PET imaging studies of dopamine D2 receptors.
Topics: Animals; Binding, Competitive; Brain; Carbon Radioisotopes; Cerebellum; Corpus Striatum; Dextroamphetamine; Dopamine Antagonists; Fluorine Radioisotopes; Haloperidol; Kinetics; Macaca mulatta; Male; Raclopride; Rats; Rats, Sprague-Dawley; Salicylamides; Tomography, Emission-Computed | 1996 |
Inverse agonism at dopamine D2 receptors. Haloperidol-induced prolactin release from GH4C1 cells transfected with the human D2 receptor is antagonized by R(-)-n-propylnorapomorphine, raclopride, and phenoxybenzamine.
Topics: Animals; Cells, Cultured; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Humans; Phenoxybenzamine; Prolactin; Raclopride; Rats; Receptors, Dopamine D2; Salicylamides | 1996 |
The effects of raclopride on vacuous jaw movements in rats following acute administration.
Topics: Animals; Antipsychotic Agents; Clozapine; Dose-Response Relationship, Drug; Extrapyramidal Tracts; Haloperidol; Injections, Intraperitoneal; Male; Mastication; Raclopride; Rats; Rats, Sprague-Dawley; Salicylamides; Stereotyped Behavior | 1996 |
Test-retest reliability of central [11C]raclopride binding at high D2 receptor occupancy. A PET study in haloperidol-treated patients.
Topics: Adult; Antipsychotic Agents; Binding Sites; Cerebellum; Corpus Striatum; Haloperidol; Humans; Middle Aged; Putamen; Raclopride; Receptors, Dopamine D2; Reproducibility of Results; Salicylamides; Schizophrenia; Tomography, Emission-Computed | 1996 |
Autoradiographic mapping of mu opioid receptor changes in rat brain after long-term haloperidol treatment: relationship to the development of vacuous chewing movements.
Topics: Animals; Antipsychotic Agents; Autoradiography; Brain; Dopamine Antagonists; Dyskinesia, Drug-Induced; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Haloperidol; Male; Mastication; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Opioid, mu; Salicylamides | 1996 |
Effects of dopamine antagonists in a two-way active avoidance procedure in rats: interactions with 8-OH-DPAT, ritanserin, and prazosin.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-Antagonists; Animals; Avoidance Learning; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Male; Prazosin; Raclopride; Rats; Rats, Sprague-Dawley; Ritanserin; Salicylamides; Serotonin Agents | 1996 |
Regulation of ionotropic glutamate receptors following subchronic and chronic treatment with typical and atypical antipsychotics.
Topics: Animals; Antipsychotic Agents; Brain; Clozapine; Haloperidol; Male; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Glutamate; Salicylamides; Time Factors | 1996 |
Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
Topics: Animals; Antipsychotic Agents; Benzamides; Benzazepines; Brain; Clozapine; Corpus Striatum; Haloperidol; Iodine Radioisotopes; Male; Organ Specificity; Raclopride; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Receptors, Serotonin; Salicylamides; Spiperone; Tetrahydronaphthalenes; Time Factors; Tritium; Up-Regulation | 1997 |
Effects of chronic neuroleptic treatments on dopamine D1 and D2 receptors: homogenate binding and autoradiographic studies.
Topics: Animals; Antipsychotic Agents; Autoradiography; Benzazepines; Chromatography, High Pressure Liquid; Clozapine; Haloperidol; Male; Neostriatum; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides | 1997 |
Effect of chronic antipsychotic drug treatment on preprosomatostatin and preprotachykinin A mRNA levels in the medial prefrontal cortex, the nucleus accumbens and the caudate putamen of the rat.
Topics: Animals; Antipsychotic Agents; Caudate Nucleus; Clozapine; Dopamine Antagonists; Haloperidol; Male; Nucleus Accumbens; Organ Specificity; Piperazines; Prefrontal Cortex; Protein Precursors; Putamen; Raclopride; Rats; Rats, Sprague-Dawley; RNA, Messenger; Salicylamides; Somatostatin; Tachykinins; Transcription, Genetic | 1997 |
Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment.
Topics: Animals; Antipsychotic Agents; Autoradiography; Benzazepines; Clozapine; Dopamine Antagonists; Haloperidol; Male; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Salicylamides; Time Factors | 1997 |
Dopamine and sodium appetite: antagonists suppress sham drinking of NaCl solutions in the rat.
Topics: Animals; Appetite; Dopamine; Dopamine Antagonists; Drinking; Haloperidol; Male; Motivation; Raclopride; Rats; Salicylamides; Saline Solution, Hypertonic; Taste; Water-Electrolyte Balance | 1997 |
The involvement of dopamine D2 receptors, but not D3 or D4 receptors, in the rewarding effect of brain stimulation in the rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Clozapine; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Male; Nucleus Accumbens; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D4; Reward; Salicylamides; Self Stimulation | 1997 |
Bidirectional effects of dopamine D2 receptor antagonists on responding for a conditioned reinforcer.
Topics: Amphetamine; Animals; Benzazepines; Conditioning, Operant; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Female; Haloperidol; Motivation; Pimozide; Raclopride; Rats; Reinforcement, Psychology; Reward; Salicylamides; Sulpiride | 1997 |
Delayed normalization of central D2 dopamine receptor availability after discontinuation of haloperidol decanoate. Preliminary findings.
Topics: Adult; Antipsychotic Agents; Basal Ganglia; Brain; Delayed-Action Preparations; Dopamine Antagonists; Female; Haloperidol; Humans; Male; Mathematics; Middle Aged; Putamen; Raclopride; Radioligand Assay; Receptors, Dopamine D2; Salicylamides; Schizophrenia; Tomography, Emission-Computed | 1997 |
Neuroleptics and dopamine transporters.
Topics: Animals; Antipsychotic Agents; Benzazepines; Clozapine; Dopamine Antagonists; Haloperidol; Male; Neostriatum; Nucleus Accumbens; Olfactory Pathways; Prosencephalon; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Substantia Nigra; Tegmentum Mesencephali | 1998 |
Activation of midline thalamic nuclei by antipsychotic drugs.
Topics: Animals; Antipsychotic Agents; Brain; Haloperidol; Male; Proto-Oncogene Proteins c-fos; Raclopride; Rats; Rats, Sprague-Dawley; Risperidone; Salicylamides; Thalamic Nuclei; Thioridazine | 1998 |
Agonist and inverse agonist activity at the dopamine D3 receptor measured by guanosine 5'--gamma-thio-triphosphate--35S- binding.
Topics: Animals; Binding, Competitive; CHO Cells; Cricetinae; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Humans; Mice; Pertussis Toxin; Quinpirole; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D3; Salicylamides; Tetrahydronaphthalenes; Virulence Factors, Bordetella | 1998 |
A novel computer-controlled conditioned avoidance apparatus for rats.
Topics: Amphetamines; Animals; Antipsychotic Agents; Avoidance Learning; Benzazepines; Clozapine; Computers; Cross-Over Studies; Dopamine Antagonists; Fluorobenzenes; Haloperidol; Male; Physical Conditioning, Animal; Piperidines; Raclopride; Rats; Rats, Sprague-Dawley; Salicylamides; Serotonin Antagonists; Serotonin Receptor Agonists | 1997 |
M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice.
Topics: Animals; Antipsychotic Agents; Clozapine; Excitatory Amino Acid Antagonists; Fluorobenzenes; Haloperidol; In Vitro Techniques; Male; Patch-Clamp Techniques; Phencyclidine; Piperidines; Prefrontal Cortex; Pyramidal Cells; Raclopride; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, N-Methyl-D-Aspartate; Receptors, Serotonin; Salicylamides; Serotonin Antagonists | 1998 |
Stimulation of forward locomotion by SCH-23390 and raclopride in d-amphetamine-treated rats.
Topics: Animals; Benzazepines; Dextroamphetamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Exploratory Behavior; Haloperidol; Male; Motor Activity; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Salicylamides; Stimulation, Chemical | 1998 |
The cataleptogenic effects of the neuroleptic nemonapride are attenuated by its 5-HT1A receptor agonist properties.
Topics: Animals; Antipsychotic Agents; Benzamides; Catalepsy; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Male; Piperazines; Pyridines; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Salicylamides; Serotonin Antagonists; Serotonin Receptor Agonists | 1998 |
Effects of dopamine antagonists and accumbens dopamine depletions on time-constrained progressive-ratio performance.
Topics: Animals; Benzazepines; Conditioning, Operant; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Male; Nucleus Accumbens; Raclopride; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Salicylamides; Time Factors | 1998 |
Haloperidol, raclopride, and eticlopride induce microcatalepsy during operant performance in rats, but clozapine and SCH 23390 do not.
Topics: Animals; Antipsychotic Agents; Benzazepines; Catalepsy; Clozapine; Conditioning, Operant; Haloperidol; Male; Raclopride; Rats; Rats, Sprague-Dawley; Salicylamides | 1998 |
Effects of chronic treatment with typical and atypical antipsychotic drugs on the rat striatum.
Topics: Animals; Antipsychotic Agents; Autoradiography; Clozapine; Corpus Striatum; Dopamine D2 Receptor Antagonists; Haloperidol; Magnetic Resonance Imaging; Male; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Salicylamides | 1999 |
Chronic haloperidol alters dopamine receptors: effects of cocaine exposure during the preweaning period.
Topics: Animals; Autoradiography; Basal Ganglia; Benzazepines; Cocaine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Female; Haloperidol; Male; Piperazines; Prosencephalon; Protein Binding; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Sex Factors; Time Factors; Weaning | 1999 |
Stimulation of dopamine release in the bed nucleus of stria terminalis. A trait of atypical antipsychotics?
Topics: Amygdala; Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Dopamine; Haloperidol; Indoles; Male; Olanzapine; Pirenzepine; Pyridines; Raclopride; Rats; Rats, Sprague-Dawley; Risperidone; Salicylamides; Thalamus | 1999 |
Effects of SCH 23390, raclopride, and haloperidol on morphine withdrawal-induced aggression in male mice.
Topics: Aggression; Animals; Antipsychotic Agents; Benzazepines; Dopamine Antagonists; Haloperidol; Male; Mice; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Raclopride; Salicylamides; Social Behavior; Substance Withdrawal Syndrome | 1999 |
The problem of antipsychotic treatment for functional imaging in Huntington's disease: receptor binding, gene expression and locomotor activity after sub-chronic administration and wash-out of haloperidol in the rat.
Topics: Animals; Antipsychotic Agents; Autoradiography; Benzazepines; Corpus Striatum; Dopamine Antagonists; Gene Expression; Haloperidol; Huntington Disease; In Situ Hybridization; Linear Models; Male; Motor Activity; Nucleus Accumbens; Raclopride; Radionuclide Imaging; Rats; Rats, Inbred Strains; Receptors, Dopamine D1; Receptors, Dopamine D2; RNA, Messenger; Substantia Nigra; Tissue Distribution | 2000 |
Sigma binding sites identified by [(3)H] DTG are elevated in aged Fischer-344 x Brown Norway (F1) rats.
Topics: Aging; Animals; Anticonvulsants; Binding Sites; Corpus Striatum; Guanidines; Haloperidol; Male; Raclopride; Rats; Rats, Inbred BN; Rats, Inbred F344; Receptors, Dopamine D2; Receptors, sigma; Tritium | 2000 |
Decreased locomotor activity after microinjection of dopamine D2/D3 receptor agonists and antagonists into lobule 9/10 of the cerebellum: a D3 receptor mediated effect?
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Cerebellum; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; Male; Microinjections; Motor Activity; Quinolines; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetrahydronaphthalenes | 2000 |
The discriminative stimulus properties of the atypical antipsychotic olanzapine in rats.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Chlorpromazine; Clozapine; Discrimination Learning; Generalization, Psychological; Haloperidol; Male; Olanzapine; Pirenzepine; Raclopride; Rats; Rats, Sprague-Dawley; Risperidone; Ritanserin; Scopolamine | 2000 |
Predicting how equipotent doses of chlorpromazine, haloperidol, sulpiride, raclopride and clozapine reduce locomotor activity in mice.
Topics: Animals; Antipsychotic Agents; Chlorpromazine; Clozapine; Female; Haloperidol; Male; Mice; Motor Activity; Raclopride; Sulpiride | 2000 |
Stoichiometry of tyrosine hydroxylase phosphorylation in the nigrostriatal and mesolimbic systems in vivo: effects of acute haloperidol and related compounds.
Topics: Animals; Benzazepines; Brain; Clozapine; Corpus Striatum; Dopamine Antagonists; Haloperidol; Hypothalamus; Male; Nucleus Accumbens; Phosphorylation; Raclopride; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2000 |
Pharmacology of [3H]R(+)-7-OH-DPAT binding in the rat caudate-putamen.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Benzopyrans; Binding, Competitive; Caudate Nucleus; Clozapine; Dopamine; Dopamine Agonists; Dopamine Antagonists; Guanidines; Guanosine Triphosphate; Haloperidol; Heterotrimeric GTP-Binding Proteins; Indans; Kinetics; Magnesium; Male; Oxazines; Protein Binding; Putamen; Quinpirole; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Remoxipride; Sodium; Specific Pathogen-Free Organisms; Sulfones; Sulpiride; Tetrahydronaphthalenes | 2001 |
The effects of antipsychotic drugs on serotonergic activity in the rat hippocampus.
Topics: Animals; Antipsychotic Agents; Dopamine D2 Receptor Antagonists; Haloperidol; Hippocampus; Hydroxyindoleacetic Acid; Ketanserin; Male; Raclopride; Rats; Rats, Wistar; Risperidone; Serotonin | 2000 |
Dopamine D(2) receptor blockade by haloperidol. (3)H-raclopride reveals much higher occupancy than EEDQ.
Topics: Animals; Dopamine Antagonists; Haloperidol; Kinetics; Male; Quinolines; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2 | 2000 |
Increased dopamine d(2) receptor occupancy and elevated prolactin level associated with addition of haloperidol to clozapine.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Clozapine; Corpus Striatum; Drug Therapy, Combination; Haloperidol; Humans; Male; Prolactin; Raclopride; Receptors, Dopamine D2; Schizophrenia; Tomography, Emission-Computed | 2001 |
Antipsychotic drugs classified by their effects on the release of dopamine and noradrenaline in the prefrontal cortex and striatum.
Topics: Animals; Antipsychotic Agents; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Haloperidol; Male; Norepinephrine; Prefrontal Cortex; Raclopride; Rats; Rats, Wistar; Receptors, Serotonin; Sulpiride | 2001 |
Antagonism at 5-HT(2A) receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats.
Topics: Animals; Avoidance Learning; Catalepsy; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Synergism; Extrapyramidal Tracts; Fluorobenzenes; Haloperidol; Male; Piperidines; Raclopride; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Serotonin; Serotonin Antagonists | 2001 |
No support for regional selectivity in clozapine-treated patients: a PET study with [(11)C]raclopride and [(11)C]FLB 457.
Topics: Adult; Antipsychotic Agents; Brain; Clozapine; Corpus Striatum; Female; Haloperidol; Humans; Male; Middle Aged; Pyrrolidines; Raclopride; Receptors, Dopamine D2; Salicylamides; Schizophrenia; Schizophrenia, Paranoid; Tomography, Emission-Computed | 2001 |
Decreased striatal dopamine efflux after intrastriatal application of benzazepine-class D1 agonists is not mediated via dopamine receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Benzodiazepines; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; Male; Neostriatum; Presynaptic Terminals; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2001 |
Effects of the atypical neuroleptic clozapine on micturition parameters in anesthetized rats.
Topics: Anesthesia; Animals; Antipsychotic Agents; Clozapine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Electric Stimulation; Female; Haloperidol; Hypogastric Plexus; Pyridines; Pyrroles; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D4; Urinary Bladder; Urination; Urination Disorders | 2001 |
Differential effects of dopamine antagonists on locomotor activity, conditioned activity and conditioned place preference induced by cocaine in rats.
Topics: Animals; Benzazepines; Cocaine; Conditioning, Operant; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Haloperidol; Male; Motor Activity; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1 | 2001 |
Differential effects of typical and atypical antipsychotic drugs on striosome and matrix compartments of the striatum.
Topics: Animals; Antipsychotic Agents; Clozapine; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Haloperidol; Male; Muscarinic Antagonists; Neostriatum; Neurons; Neuropil; Proto-Oncogene Proteins c-fos; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Neurotransmitter; Serotonin Antagonists | 2002 |
Evidence for dopamine D(1) receptor involvement in the stimulus selection task: overshadowing in the rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Analysis of Variance; Animals; Avoidance Learning; Benzazepines; Conditioning, Psychological; Discrimination Learning; Dopamine Agents; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Haloperidol; Male; Raclopride; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2002 |
The relationship between dopamine D2 receptor occupancy and the vacuous chewing movement syndrome in rats.
Topics: Animals; Antipsychotic Agents; Cerebellum; Corpus Striatum; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Haloperidol; Male; Mastication; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Stereotyped Behavior | 2003 |
Chlorpromazine inhibits the glucocorticoid receptor-mediated gene transcription in a calcium-dependent manner.
Topics: Animals; Antipsychotic Agents; Calcimycin; Calcium; Calcium Channel Blockers; Cell Line; Cell Line, Transformed; Chloramphenicol O-Acetyltransferase; Chlorpromazine; Clozapine; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Estrenes; Fibroblasts; Gene Expression Regulation; Genes, Reporter; Haloperidol; Histamine; Histamine H1 Antagonists; Ionophores; Mammary Tumor Virus, Mouse; Mice; Nifedipine; Phorbol Esters; Phosphodiesterase Inhibitors; Protein Kinase C; Protein Kinase C-alpha; Pyrilamine; Pyrrolidinones; Raclopride; Receptors, Glucocorticoid; Remoxipride; Sulfonamides; Sulpiride; Tetradecanoylphorbol Acetate; Thionucleotides; Transcription, Genetic; Type C Phospholipases | 2002 |
Respective roles of dopamine D2 and D3 receptors in food-seeking behaviour in rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amisulpride; Analysis of Variance; Animals; Apomorphine; Benzazepines; Benzopyrans; Conditioning, Operant; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Synergism; Feeding Behavior; Haloperidol; Male; Naphthalenes; Pyrroles; Pyrrolidines; Quinolines; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; Reinforcement, Psychology; Sulpiride; Tetrahydronaphthalenes | 2003 |
Sigma1 and dopamine D2 receptor occupancy in the mouse brain after a single administration of haloperidol and two dopamine D2-like receptor ligands.
Topics: Animals; Benzamides; Brain; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Haloperidol; Injections, Intraperitoneal; Ligands; Male; Mice; Nootropic Agents; Piperazines; Raclopride; Receptors, Dopamine D2; Receptors, sigma | 2003 |
Role of NR2B-containing N-methyl-D-aspartate receptors in haloperidol-induced c-Fos expression in the striatum and nucleus accumbens.
Topics: Animals; Cell Count; Corpus Striatum; Dizocilpine Maleate; Dopamine Antagonists; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Haloperidol; Immunohistochemistry; Nucleus Accumbens; Phenols; Piperidines; Proto-Oncogene Proteins c-fos; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 2003 |
Influence of tacrine on dopamine-induced reactions of the gastric smooth muscle of rats.
Topics: Animals; Atropine; Dopamine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Haloperidol; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Raclopride; Rats; Rats, Wistar; Receptors, Cholinergic; Receptors, Dopamine D2; Stomach; Tacrine; Time Factors | 2004 |
Continuous but not intermittent olanzapine infusion induces vacuous chewing movements in rats.
Topics: Analysis of Variance; Animals; Behavior, Animal; Benzodiazepines; Disease Models, Animal; Dopamine Antagonists; Drug Administration Routes; Dyskinesia, Drug-Induced; Haloperidol; Infusion Pumps; Male; Mastication; Olanzapine; Raclopride; Radioligand Assay; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Selective Serotonin Reuptake Inhibitors; Time Factors; Tritium | 2005 |
Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic.
Topics: Animals; Antipsychotic Agents; Aripiprazole; Binding, Competitive; Cell Membrane; CHO Cells; Colforsin; Cricetinae; Cricetulus; Cyclic AMP; DNA, Complementary; Dopamine; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Humans; Lisuride; Piperazines; Piperidines; Quinolones; Raclopride; Radioligand Assay; Receptors, Dopamine D2; Risperidone; Transfection; Tritium | 2005 |
Use of LC/MS to assess brain tracer distribution in preclinical, in vivo receptor occupancy studies: dopamine D2, serotonin 2A and NK-1 receptors as examples.
Topics: Animals; Antipsychotic Agents; Aprepitant; Benzodiazepines; Brain; Chromatography, High Pressure Liquid; Clozapine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Evaluation, Preclinical; Fluorobenzenes; Gerbillinae; Haloperidol; Male; Mass Spectrometry; Morpholines; Neurokinin-1 Receptor Antagonists; Olanzapine; Piperidines; Raclopride; Rats; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Neurokinin-1; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Tetrazoles | 2005 |
Subchronic haloperidol increases CB(1) receptor binding and G protein coupling in discrete regions of the basal ganglia.
Topics: Analgesics; Animals; Basal Ganglia; Binding, Competitive; Cyclohexanols; Dopamine Antagonists; Drug Administration Schedule; Drug Interactions; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Male; Raclopride; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptors, Dopamine D2; Receptors, G-Protein-Coupled; Up-Regulation | 2005 |
Chronic neuroleptic treatment reduces endogenous kynurenic acid levels in rat brain.
Topics: Animals; Antipsychotic Agents; Brain; Chromatography, High Pressure Liquid; Clozapine; Haloperidol; Kynurenic Acid; Kynurenine; Male; Microdialysis; Raclopride; Rats; Rats, Sprague-Dawley; Time Factors | 2006 |
Prototypical antipsychotic drugs protect hippocampal neuronal cultures against cell death induced by growth medium deprivation.
Topics: Animals; Anisoles; Antipsychotic Agents; Benzazepines; Butaclamol; Caspase Inhibitors; Cell Death; Cells, Cultured; Chlorpromazine; Clozapine; Domperidone; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Ginkgo biloba; Haloperidol; Hippocampus; Indans; Isoxazoles; Neurons; Neuroprotective Agents; Peptides; Piperidines; Plant Extracts; Propylamines; Raclopride; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptors, N-Methyl-D-Aspartate; Remoxipride; Risperidone; Sulpiride | 2006 |
Dose determination of haloperidol, risperidone and olanzapine using an in vivo dopamine D2-receptor occupancy method in the rat.
Topics: Algorithms; Analysis of Variance; Animals; Antipsychotic Agents; Benzodiazepines; Binding, Competitive; Cerebellum; Corpus Striatum; Dose-Response Relationship, Drug; Haloperidol; Male; Olanzapine; Raclopride; Radioligand Assay; Rats; Rats, Wistar; Receptors, Dopamine D2; Risperidone; Tritium | 2006 |
L-type calcium channel blockade on haloperidol-induced c-Fos expression in the striatum.
Topics: Animals; Antipsychotic Agents; Benzazepines; Blotting, Western; Calcium Channel Blockers; Calcium Channels, L-Type; Catalepsy; Cyclic AMP Response Element-Binding Protein; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; ets-Domain Protein Elk-1; Gene Expression; Genes, fos; Haloperidol; Immunohistochemistry; Male; Neostriatum; Nifedipine; Nimodipine; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1 | 2007 |
Dopamine binds to alpha(2)-adrenergic receptors in the song control system of zebra finches (Taeniopygia guttata).
Topics: Adrenergic alpha-Antagonists; Animals; Brain; Clozapine; Dopamine; Finches; Haloperidol; Homeostasis; Idazoxan; Male; Raclopride; Receptors, Adrenergic, alpha-2; Vocalization, Animal | 2008 |
Using pharmacokinetic-pharmacodynamic modelling as a tool for prediction of therapeutic effective plasma levels of antipsychotics.
Topics: Administration, Oral; Animals; Antipsychotic Agents; Basal Ganglia; Behavior, Animal; Benzodiazepines; Binding, Competitive; Clozapine; Conditioning, Psychological; Dopamine Antagonists; Haloperidol; Imidazoles; Indoles; Injections, Subcutaneous; Male; Models, Biological; Olanzapine; Protein Binding; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D2; Reproducibility of Results; Risperidone | 2008 |
D2-receptor upregulation is dependent upon temporal course of D2-occupancy: a longitudinal [11C]-raclopride PET study in cats.
Topics: Animals; Cats; Corpus Striatum; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Tolerance; Haloperidol; Longitudinal Studies; Motor Activity; Positron-Emission Tomography; Raclopride; Receptors, Dopamine D2; Up-Regulation | 2009 |
Clozapine-induced ERK1 and ERK2 signaling in prefrontal cortex is mediated by the EGF receptor.
Topics: Animals; Antipsychotic Agents; Cells, Cultured; Cholinergic Agents; Clozapine; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Enzyme Inhibitors; ErbB Receptors; GTP-Binding Protein alpha Subunits, Gi-Go; Haloperidol; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neurons; Prefrontal Cortex; Raclopride; Serotonin Agents; Signal Transduction; Type C Phospholipases | 2009 |
Antipsychotics affect multiple calcium calmodulin dependent proteins.
Topics: Animals; Antipsychotic Agents; Calcineurin; Calcium-Calmodulin-Dependent Protein Kinase Kinase; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinase Type 4; Calcium-Calmodulin-Dependent Protein Kinases; Calmodulin; Clozapine; Corpus Striatum; Dopamine Antagonists; Haloperidol; Male; Psychotropic Drugs; Raclopride; Rats; Rats, Sprague-Dawley; Risperidone; RNA, Messenger | 2009 |
Contribution of the central dopaminergic system in the anti-hypertensive effect of kinin B1 receptor antagonists in two rat models of hypertension.
Topics: Analysis of Variance; Animals; Blood Pressure; Bradykinin B1 Receptor Antagonists; Brain; Disease Models, Animal; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Hypertension; Male; Raclopride; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Bradykinin B1 | 2010 |
Dopamine on D2-like receptors "reboosts" dopamine D1-like receptor-mediated behavioural activation in rats licking for sucrose.
Topics: Animals; Benzazepines; Biomechanical Phenomena; Cues; Dietary Sucrose; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drinking; Drinking Behavior; Extinction, Psychological; Haloperidol; Male; Motivation; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Reward; Time Factors | 2010 |
Blockade of tachykinin NK3 receptor reverses hypertension through a dopaminergic mechanism in the ventral tegmental area of spontaneously hypertensive rats.
Topics: Animals; Benzazepines; Blood Pressure; Dopamine; Haloperidol; Heart Rate; Hypertension; Ibotenic Acid; Indoles; Male; Oligopeptides; Peptide Fragments; Quinolines; Raclopride; Rats; Rats, Inbred SHR; Receptors, Neurokinin-3; Substance P; Ventral Tegmental Area | 2010 |
Role of the dopaminergic system in the acquisition, expression and reinstatement of MDMA-induced conditioned place preference in adolescent mice.
Topics: Animals; Benzazepines; Blotting, Western; Conditioning, Operant; Dopamine; Dopamine Antagonists; Haloperidol; Male; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Raclopride; Serotonin; Thiazepines | 2012 |
Early life stress causes refractoriness to haloperidol-induced catalepsy.
Topics: Animals; Antipsychotic Agents; Apomorphine; Catalepsy; Catecholamines; Cerebral Cortex; Dopamine Agonists; Female; Globus Pallidus; Haloperidol; Male; Maternal Exposure; Maternal-Fetal Relations; Pregnancy; Proto-Oncogene Proteins c-fos; Raclopride; Rats; Receptors, Dopamine; Stress, Physiological; Subthalamic Nucleus; Ventral Thalamic Nuclei | 2013 |
Systemic blockade of dopamine D2-like receptors increases high-voltage spindles in the globus pallidus and motor cortex of freely moving rats.
Topics: Animals; Benzazepines; Brain Waves; Dopamine D2 Receptor Antagonists; Gene Knockdown Techniques; Globus Pallidus; Haloperidol; Locomotion; Male; Motor Cortex; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2013 |
A systematic microdialysis study of dopamine transmission in the accumbens shell/core and prefrontal cortex after acute antipsychotics.
Topics: Administration, Intravenous; Animals; Antipsychotic Agents; Chlorpromazine; Clozapine; Dopamine; Haloperidol; Male; Microdialysis; Nucleus Accumbens; Prefrontal Cortex; Raclopride; Rats; Rats, Sprague-Dawley; Risperidone; Time Factors | 2015 |